Most United States laboratories report a reference range of roughly 160 to 950 pg/mL, though exact figures differ between labs, so a result should be read against the range printed on your own vitamin B12 blood test report
The primary treatment period starts at the first dose of Week 1 and ends at the last visit on or prior to Week 48
Common side effects associated with their use include erythema, itching, and burning sensations [162]
In relation to the risk of developing cancer, a study published in The Journal of Clinical Endocrinology & Metabolism found no significant association between the dose of rhGH, mortality, and cancer incidence, making causality far less likely: Safety concerns have been raised regarding premature mortality, diabetes, neoplasia, and cerebrovascular disease in association with GH therapy